Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool von Priesterbach‐Ackley, L. P., Boldt, H. B., Petersen, J. K., Bervoets, N., Scheie, D., Ulhøi, B. P., Gardberg, M., Brännström, T., Torp, S. H., Aronica, E., Küsters, B., den Dunnen, W. F. A., Vos, F. Y. F. L., Wesseling, P., Leng, W. W. J., Kristensen, B. W.

Volltext

Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials von Zeverijn, Laurien J., Looze, Eleonora J., Thavaneswaran, Subotheni, Berge Henegouwen, J. Maxime, Simes, Robert J., Hoes, Louisa R., Sjoquist, Katrin M., Wijngaart, Hanneke, Sebastian, Lucille, Geurts, Birgit S., Lee, Chee K., Wit, Gijsbrecht F., Espinoza, David, Roepman, Paul, Lin, Frank P., Jansen, Anne M. L., Leng, Wendy W. J., Noort, Vincent, Leek, Lindsay V. M., Vos, Filip Y. F. L., Herpen, Carla M. L., Gelderblom, Hans, Verheul, Henk M. W., Thomas, David M., Voest, Emile E.

Volltext

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer von Guman, Noori A. M., van Geffen, Roos J., Mulder, Frits I., van Haaps, Thijs F., Hovsepjan, Vahram, Labots, Mariette, Cirkel, Geert A., Y. F. L. de Vos, Filip, ten Tije, Albert J., Beerepoot, Laurens V., Tjan‐Heijnen, Vivianne C. G., van Laarhoven, Hanneke W. M., Hamberg, Paul, Vulink, Annelie J. E., Los, Maartje, Zwinderman, Aeilko H., Ferwerda, Bart, Lolkema, Martijn P. J. K., Steeghs, Neeltje, Büller, Harry R., Kamphuisen, Pieter W., van Es, Nick

Volltext

Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study von van der Velden, Naomi C. A, van Laarhoven, Hanneke W. M, Burgers, Sjaak A, Hendriks, Lizza E. L, de Vos, Filip Y. F. L, Dingemans, Anne-Marie C, Jansen, Joost, van Haarst, Jan-Maarten W, Dits, Joyce, Smets, Ellen MA, Henselmans, Inge

Volltext

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial von Subbiah, Vivek, Kreitman, Robert J., Wainberg, Zev A., Gazzah, Anas, Lassen, Ulrik, Stein, Alexander, Wen, Patrick Y., Dietrich, Sascha, de Jonge, Maja J. A., Blay, Jean-Yves, Italiano, Antoine, Yonemori, Kan, Cho, Daniel C., de Vos, Filip Y. F. L., Moreau, Philippe, Fernandez, Elena Elez, Schellens, Jan H. M., Zielinski, Christoph C., Redhu, Suman, Boran, Aislyn, Passos, Vanessa Q., Ilankumaran, Palanichamy, Bang, Yung-Jue

Volltext

A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumor... von Gietema, J. A., Hoekstra, R., de Vos, F. Y. F. L., Uges, D. R. A., van der Gaast, A., Groen, H. J. M., Loos, W. J., Knight, R. A., Carr, R. A., Humerickhouse, R. A., Eskens, F. A. L. M.

Volltext

Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis von Senders, Joeky T., Goldhaber, Nicole H., Cote, David J., Muskens, Ivo S., Dawood, Hassan Y., De Vos, Filip Y. F. L., Gormley, William B., Smith, Timothy R., Broekman, Marike L. D.

Volltext

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cance... von van Geel, Robin M. J. M., van Brummelen, Emilie M. J., Eskens, Ferry A. L. M., Huijberts, Sanne C. F. A., de Vos, Filip Y. F. L., Lolkema, Martijn P. J. K., Devriese, Lot A., Opdam, Frans L., Marchetti, Serena, Steeghs, Neeltje, Monkhorst, Kim, Thijssen, Bas, Rosing, Hilde, Huitema, Alwin D. R., Beijnen, Jos H., Bernards, René, Schellens, Jan H. M.

Volltext

Cognitive impairments are independently associated with shorter survival in diffuse glioma patients von van Kessel, Emma, Huenges Wajer, Irene M. C., Ruis, Carla, Seute, Tatjana, Fonville, Susanne, De Vos, Filip Y. F. L., Verhoeff, Joost J. C., Robe, Pierre A., van Zandvoort, Martine J. E., Snijders, Tom J.

Volltext

Brain metastases in adult patients with melanoma of unknown primary in the Netherlands (2011–2020) von Padilla, C. S., Ho, V. K. Y., Mooijenkind, T. W. A. N., Louwman, M. W. J., de Vos, F. Y. F. L., Bekkenk, M. W., Minnaard, W. A., Loef, C., van Zanten, S. E. M. Veldhuijzen

Volltext

Prognostic factors among patients with brain metastases from cancer of unknown primary site von Simões Padilla, C., Ho, V. K. Y., van der Strate, I. H., Leenders, W. P. J., de Vos, F. Y. F. L., Veldhuijzen van Zanten, S. E. M., Loef, C.

Volltext

Blended online learning for oncologists to improve skills in shared decision making about palliative chemotherapy: a pre-posttest evaluation von Bos-van den Hoek, D. W., van Laarhoven, H. W. M., Ali, R., Bakker, S. D., Goosens, A., Hendriks, M. P., Pepels, M. J. A. E., Tange, D., de Vos, F. Y. F. L., van de Wouw, A. J., Smets, E. M. A., Henselmans, I.

Volltext

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520 von Verheijen, Remy B., van der Biessen, Diane A. J., Hotte, Sebastien J., Siu, Lillian L., Spreafico, Anna, de Jonge, Maja J. A., Pronk, Linda C., De Vos, Filip Y. F. L., Schnell, David, Hirte, Hal W., Steeghs, Neeltje, Lolkema, Martijn P.

Volltext

Focused Ultrasound-Enhanced Liquid Biopsy: A Promising Diagnostic Tool for Brain Tumor Patients von Bakker, Akke, Ixkes, Anna E, Venugopal, Hema, Ries, Mario G, Lak, Nathalie S M, de Vos, Filip Y F L, van Vuurden, Dannis G, Snijders, Tom J

Volltext

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies von de Jonge, Maja J. A., Steeghs, Neeltje, Lolkema, Martijn P., Hotte, Sebastien J., Hirte, Hal W., van der Biessen, Diane A. J., Abdul Razak, Albiruni R., De Vos, Filip Y. F. L., Verheijen, Remy B., Schnell, David, Pronk, Linda C., Jansen, Monique, Siu, Lillian L.

Volltext

Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment von DE GRAAN, Anne-Joy M, TEUNISSEN, Sebastiaan F, SEYNAEVE, Caroline, BEIJNEN, Jos H, MATHIJSSEN, Ron H. J, DE VOS, Filip Y. F. L, LOOS, Walter J, VAN SCHAIK, Ron H. N, DE JONGH, Felix E, DE VOS, Aad I, VAN ALPHEN, Robbert J, VAN DER HOLT, Bronno, VERWEIJ, Jaap

Volltext

Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours von Plummer, Ruth, Verheul, Henk M., De Vos, Filip Y. F. L., Leunen, Karin, Molife, L. Rhoda, Rolfo, Christian, Grundtvig-Sørensen, Peter, De Grève, Jacques, Rottey, Sylvie, Jerusalem, Guy, Italiano, Antoine, Spicer, James, Dirix, Luc, Goessl, Carsten, Birkett, Joseph, Spencer, Stuart, Learoyd, Maria, Bailey, Christopher, Dean, Emma

Volltext

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma von van Kessel, Emma, Schuit, Ewoud, Wajer, Irene M. C. Huenges, Ruis, Carla, De Vos, Filip Y. F. L., Verhoeff, Joost J. C., Seute, Tatjana, van Zandvoort, Martine J. E., Robe, Pierre A., Snijders, Tom J.

Volltext

Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline von De Vos, F.Y.F.L, van Laarhoven, H.W.M, Laven, J.S.E, Themmen, A.P.N, Beex, L.V.A.M, Sweep, C.G.J, Seynaeve, C, Jager, A

Volltext

Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma von Schuler, Martin, Zimmer, Lisa, Kim, Kevin B, Sosman, Jeffrey A, Ascierto, Paolo A, Postow, Michael A, De Vos, Filip Y F L, van Herpen, Carla M L, Carlino, Matteo S, Johnson, Douglas B, Berking, Carola, Reddy, Micaela B, Harney, Allison S, Berlin, Jordan D, Amaria, Rodabe N

Volltext